nodes	percent_of_prediction	percent_of_DWPC	metapath
Norgestimate—Progesterone Congeners—Medroxyprogesterone Acetate—uterine cancer	0.32	1	CiPCiCtD
Norgestimate—Progesterone—uterine cancer	0.225	1	CrCtD
Norgestimate—PGR—uterine cancer	0.0878	0.613	CbGaD
Norgestimate—ESR1—uterine cancer	0.0554	0.387	CbGaD
Norgestimate—PGR—Medroxyprogesterone Acetate—uterine cancer	0.0475	0.32	CbGbCtD
Norgestimate—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.033	0.222	CbGbCtD
Norgestimate—PGR—Progesterone—uterine cancer	0.0315	0.212	CbGbCtD
Norgestimate—ESR1—Progesterone—uterine cancer	0.0218	0.147	CbGbCtD
Norgestimate—Ethynodiol—Medroxyprogesterone Acetate—uterine cancer	0.0203	0.14	CrCrCtD
Norgestimate—Nandrolone decanoate—Progesterone—uterine cancer	0.0188	0.13	CrCrCtD
Norgestimate—Nandrolone phenpropionate—Progesterone—uterine cancer	0.0188	0.13	CrCrCtD
Norgestimate—Ethynodiol—Progesterone—uterine cancer	0.0177	0.122	CrCrCtD
Norgestimate—Levonorgestrel—Progesterone—uterine cancer	0.013	0.0902	CrCrCtD
Norgestimate—Norethindrone—Progesterone—uterine cancer	0.0105	0.0724	CrCrCtD
Norgestimate—Testosterone Propionate—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0699	CrCrCtD
Norgestimate—Progesterone—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0699	CrCrCtD
Norgestimate—Testosterone Propionate—Progesterone—uterine cancer	0.00882	0.061	CrCrCtD
Norgestimate—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.00878	0.0607	CrCrCtD
Norgestimate—Testosterone—Progesterone—uterine cancer	0.00765	0.0529	CrCrCtD
Norgestimate—ABCC2—Carboplatin—uterine cancer	0.00612	0.0412	CbGbCtD
Norgestimate—ABCC2—Etoposide—uterine cancer	0.00514	0.0346	CbGbCtD
Norgestimate—ABCC2—Doxorubicin—uterine cancer	0.0035	0.0236	CbGbCtD
Norgestimate—PGR—corpus luteum—uterine cancer	0.00346	0.285	CbGeAlD
Norgestimate—PGR—oviduct—uterine cancer	0.00119	0.098	CbGeAlD
Norgestimate—ESR1—oviduct—uterine cancer	0.00093	0.0766	CbGeAlD
Norgestimate—PGR—artery—uterine cancer	0.000788	0.0649	CbGeAlD
Norgestimate—PGR—myometrium—uterine cancer	0.00038	0.0313	CbGeAlD
Norgestimate—PGR—epithelium—uterine cancer	0.000299	0.0246	CbGeAlD
Norgestimate—ESR1—myometrium—uterine cancer	0.000298	0.0245	CbGeAlD
Norgestimate—PGR—uterine cervix—uterine cancer	0.000296	0.0244	CbGeAlD
Norgestimate—PGR—smooth muscle tissue—uterine cancer	0.000288	0.0237	CbGeAlD
Norgestimate—PGR—decidua—uterine cancer	0.000282	0.0232	CbGeAlD
Norgestimate—PGR—endometrium—uterine cancer	0.000268	0.0221	CbGeAlD
Norgestimate—PGR—uterus—uterine cancer	0.000247	0.0203	CbGeAlD
Norgestimate—ABCC2—renal system—uterine cancer	0.000238	0.0196	CbGeAlD
Norgestimate—ESR1—epithelium—uterine cancer	0.000234	0.0192	CbGeAlD
Norgestimate—ESR1—uterine cervix—uterine cancer	0.000232	0.0191	CbGeAlD
Norgestimate—ESR1—smooth muscle tissue—uterine cancer	0.000225	0.0185	CbGeAlD
Norgestimate—PGR—female reproductive system—uterine cancer	0.000222	0.0183	CbGeAlD
Norgestimate—ESR1—decidua—uterine cancer	0.000221	0.0182	CbGeAlD
Norgestimate—ESR1—renal system—uterine cancer	0.000217	0.0178	CbGeAlD
Norgestimate—ESR1—endometrium—uterine cancer	0.000209	0.0173	CbGeAlD
Norgestimate—ABCC2—ABC-family proteins mediated transport—ABCC9—uterine cancer	0.000203	0.0392	CbGpPWpGaD
Norgestimate—PGR—female gonad—uterine cancer	0.000202	0.0166	CbGeAlD
Norgestimate—PGR—vagina—uterine cancer	0.000201	0.0165	CbGeAlD
Norgestimate—PGR—Ovarian Infertility Genes—MLH1—uterine cancer	0.000196	0.0379	CbGpPWpGaD
Norgestimate—ESR1—uterus—uterine cancer	0.000193	0.0159	CbGeAlD
Norgestimate—ABCC2—female reproductive system—uterine cancer	0.000191	0.0157	CbGeAlD
Norgestimate—ESR1—female reproductive system—uterine cancer	0.000173	0.0143	CbGeAlD
Norgestimate—PGR—Ovarian Infertility Genes—ESR2—uterine cancer	0.000163	0.0316	CbGpPWpGaD
Norgestimate—ESR1—female gonad—uterine cancer	0.000158	0.013	CbGeAlD
Norgestimate—ESR1—vagina—uterine cancer	0.000157	0.0129	CbGeAlD
Norgestimate—PGR—Ovarian Infertility Genes—CYP19A1—uterine cancer	0.000148	0.0287	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptors—ESR2—uterine cancer	0.000142	0.0276	CbGpPWpGaD
Norgestimate—PGR—lymph node—uterine cancer	0.00013	0.0107	CbGeAlD
Norgestimate—Ethynodiol—PGR—uterine cancer	0.000125	0.0949	CrCbGaD
Norgestimate—PGR—Ovarian Infertility Genes—SMAD3—uterine cancer	0.000121	0.0235	CbGpPWpGaD
Norgestimate—Norelgestromin—PGR—uterine cancer	0.000118	0.0896	CrCbGaD
Norgestimate—Allylestrenol—PGR—uterine cancer	0.000118	0.0896	CrCbGaD
Norgestimate—Desogestrel—PGR—uterine cancer	0.000114	0.0862	CrCbGaD
Norgestimate—PGR—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.000113	0.0218	CbGpPWpGaD
Norgestimate—ABCC2—lymph node—uterine cancer	0.000111	0.00918	CbGeAlD
Norgestimate—ESR1—lymph node—uterine cancer	0.000101	0.00836	CbGeAlD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—NFE2L2—uterine cancer	0.0001	0.0193	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptors—PGR—uterine cancer	9.5e-05	0.0184	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	9.39e-05	0.0182	CbGpPWpGaD
Norgestimate—ESR1—Nuclear signaling by ERBB4—PGR—uterine cancer	9.3e-05	0.018	CbGpPWpGaD
Norgestimate—Etonogestrel—PGR—uterine cancer	9.19e-05	0.0698	CrCbGaD
Norgestimate—ESR1—Signaling events mediated by HDAC Class II—YWHAE—uterine cancer	9.06e-05	0.0175	CbGpPWpGaD
Norgestimate—Nandrolone phenpropionate—CYP19A1—uterine cancer	8.85e-05	0.0672	CrCbGaD
Norgestimate—PGR—Nuclear Receptors—ESR1—uterine cancer	8.64e-05	0.0167	CbGpPWpGaD
Norgestimate—PGR—Nuclear signaling by ERBB4—ESR1—uterine cancer	8.46e-05	0.0164	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptors—ESR2—uterine cancer	8.36e-05	0.0162	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—YWHAE—uterine cancer	8.21e-05	0.0159	CbGpPWpGaD
Norgestimate—Ethynodiol—ESR1—uterine cancer	7.88e-05	0.0599	CrCbGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—ESR2—uterine cancer	7.87e-05	0.0152	CbGpPWpGaD
Norgestimate—ESR1—Nuclear Receptor transcription pathway—PGR—uterine cancer	7.5e-05	0.0145	CbGpPWpGaD
Norgestimate—Allylestrenol—ESR1—uterine cancer	7.45e-05	0.0566	CrCbGaD
Norgestimate—Desogestrel—ESR1—uterine cancer	7.17e-05	0.0544	CrCbGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K4—uterine cancer	6.91e-05	0.0134	CbGpPWpGaD
Norgestimate—ESR1—LKB1 signaling events—STK11—uterine cancer	6.88e-05	0.0133	CbGpPWpGaD
Norgestimate—PGR—Nuclear Receptor transcription pathway—ESR1—uterine cancer	6.83e-05	0.0132	CbGpPWpGaD
Norgestimate—PGR—Ovarian Infertility Genes—CDKN1B—uterine cancer	6.74e-05	0.013	CbGpPWpGaD
Norgestimate—Nandrolone decanoate—CYP19A1—uterine cancer	6.7e-05	0.0509	CrCbGaD
Norgestimate—ESR1—Nuclear Receptor transcription pathway—ESR2—uterine cancer	6.61e-05	0.0128	CbGpPWpGaD
Norgestimate—Levonorgestrel—PGR—uterine cancer	6.5e-05	0.0494	CrCbGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—PGR—uterine cancer	6.26e-05	0.0121	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—uterine cancer	6.22e-05	0.012	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—IRF1—uterine cancer	6.09e-05	0.0118	CbGpPWpGaD
Norgestimate—Etonogestrel—ESR1—uterine cancer	5.8e-05	0.0441	CrCbGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—ESR1—uterine cancer	5.69e-05	0.011	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—YWHAE—uterine cancer	5.69e-05	0.011	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—ESR2—uterine cancer	5.51e-05	0.0107	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—BIRC5—uterine cancer	5.42e-05	0.0105	CbGpPWpGaD
Norgestimate—Norethindrone—PGR—uterine cancer	5.27e-05	0.04	CrCbGaD
Norgestimate—ESR1—ATF-2 transcription factor network—SOCS3—uterine cancer	5e-05	0.00967	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MSH6—uterine cancer	4.54e-05	0.00879	CbGpPWpGaD
Norgestimate—ABCC2—NRF2 pathway—NFE2L2—uterine cancer	4.47e-05	0.00864	CbGpPWpGaD
Norgestimate—Levonorgestrel—CYP19A1—uterine cancer	4.46e-05	0.0339	CrCbGaD
Norgestimate—ABCC2—NRF2 pathway—GPX3—uterine cancer	4.26e-05	0.00824	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—SOCS3—uterine cancer	4.13e-05	0.00798	CbGpPWpGaD
Norgestimate—Levonorgestrel—ESR1—uterine cancer	4.1e-05	0.0312	CrCbGaD
Norgestimate—ESR1—Regulation of Telomerase—SMAD3—uterine cancer	3.9e-05	0.00754	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	3.86e-05	0.00747	CbGpPWpGaD
Norgestimate—Testosterone—CYP11A1—uterine cancer	3.85e-05	0.0292	CrCbGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—uterine cancer	3.71e-05	0.00718	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—MSH2—uterine cancer	3.69e-05	0.00713	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—CDKN2A—uterine cancer	3.59e-05	0.00695	CbGpPWpGaD
Norgestimate—PGR—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	3.4e-05	0.00657	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	3.39e-05	0.00656	CbGpPWpGaD
Norgestimate—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	3.35e-05	0.00647	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—FGFR2—uterine cancer	3.33e-05	0.00644	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PGR—uterine cancer	3.13e-05	0.00606	CbGpPWpGaD
Norgestimate—Progesterone—PGR—uterine cancer	3.07e-05	0.0233	CrCbGaD
Norgestimate—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	3.07e-05	0.00593	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—PHF1—uterine cancer	3e-05	0.0058	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	2.96e-05	0.00572	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—ESR1—uterine cancer	2.85e-05	0.00551	CbGpPWpGaD
Norgestimate—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	2.79e-05	0.0054	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	2.74e-05	0.0053	CbGpPWpGaD
Norgestimate—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	2.73e-05	0.00529	CbGpPWpGaD
Norgestimate—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	2.69e-05	0.00521	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	2.66e-05	0.00515	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	2.6e-05	0.00502	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—CHD4—uterine cancer	2.55e-05	0.00493	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	2.52e-05	0.00487	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	2.52e-05	0.00487	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	2.48e-05	0.0048	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.48e-05	0.00479	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	2.46e-05	0.00476	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	2.43e-05	0.0047	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	2.39e-05	0.00462	CbGpPWpGaD
Norgestimate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	2.31e-05	0.00447	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.3e-05	0.00444	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	2.29e-05	0.00444	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	2.16e-05	0.00419	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	2.16e-05	0.00419	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	2.16e-05	0.00418	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—SUZ12—uterine cancer	2.14e-05	0.00413	CbGpPWpGaD
Norgestimate—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	2.13e-05	0.00412	CbGpPWpGaD
Norgestimate—ABCC2—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.12e-05	0.0041	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	2.11e-05	0.00409	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	2.11e-05	0.00407	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—ERBB2—uterine cancer	2.09e-05	0.00405	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.09e-05	0.00405	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	2.09e-05	0.00403	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	2e-05	0.00386	CbGpPWpGaD
Norgestimate—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	1.99e-05	0.00386	CbGpPWpGaD
Norgestimate—Testosterone—CYP19A1—uterine cancer	1.99e-05	0.0151	CrCbGaD
Norgestimate—ESR1—LKB1 signaling events—TP53—uterine cancer	1.96e-05	0.00379	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	1.95e-05	0.00378	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	1.95e-05	0.00377	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	1.95e-05	0.00377	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—ESR2—uterine cancer	1.94e-05	0.00376	CbGpPWpGaD
Norgestimate—Progesterone—ESR1—uterine cancer	1.94e-05	0.0147	CrCbGaD
Norgestimate—PGR—Signaling by ERBB4—CDKN1B—uterine cancer	1.94e-05	0.00375	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.87e-05	0.00362	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—EP300—uterine cancer	1.86e-05	0.00359	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PTEN—uterine cancer	1.78e-05	0.00345	CbGpPWpGaD
Norgestimate—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	1.78e-05	0.00344	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PHF1—uterine cancer	1.76e-05	0.0034	CbGpPWpGaD
Norgestimate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	1.72e-05	0.00333	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	1.65e-05	0.0032	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—NRAS—uterine cancer	1.59e-05	0.00308	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—CDKN2B—uterine cancer	1.58e-05	0.00306	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—CHD4—uterine cancer	1.5e-05	0.00289	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	1.46e-05	0.00283	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—SMAD3—uterine cancer	1.45e-05	0.0028	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—KRAS—uterine cancer	1.37e-05	0.00265	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AKR1B10—uterine cancer	1.35e-05	0.00261	CbGpPWpGaD
Norgestimate—ESR1—AP-1 transcription factor network—TP53—uterine cancer	1.33e-05	0.00257	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—PGR—uterine cancer	1.3e-05	0.00251	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—PIK3CA—uterine cancer	1.26e-05	0.00243	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—SUZ12—uterine cancer	1.25e-05	0.00242	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	1.23e-05	0.00237	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—HRAS—uterine cancer	1.2e-05	0.00233	CbGpPWpGaD
Norgestimate—PGR—Generic Transcription Pathway—ESR1—uterine cancer	1.18e-05	0.00228	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—HRAS—uterine cancer	1.16e-05	0.00225	CbGpPWpGaD
Norgestimate—ESR1—Regulation of Telomerase—AKT1—uterine cancer	1.15e-05	0.00222	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	1.14e-05	0.00221	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	1.14e-05	0.0022	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—RNF43—uterine cancer	1.12e-05	0.00216	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	1.08e-05	0.00209	CbGpPWpGaD
Norgestimate—ESR1—Leptin signaling pathway—AKT1—uterine cancer	1.06e-05	0.00205	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	1.05e-05	0.00204	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PTEN—uterine cancer	1.05e-05	0.00202	CbGpPWpGaD
Norgestimate—PGR—Signaling by ERBB4—AKT1—uterine cancer	1.03e-05	0.00199	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—INHBA—uterine cancer	1.02e-05	0.00198	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.02e-05	0.00198	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—EZH2—uterine cancer	1.01e-05	0.00195	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	1e-05	0.00194	CbGpPWpGaD
Norgestimate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	9.98e-06	0.00193	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	9.51e-06	0.00184	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	9.47e-06	0.00183	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—ESR2—uterine cancer	9.36e-06	0.00181	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—NRAS—uterine cancer	9.34e-06	0.00181	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	9.29e-06	0.0018	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AKR1C1—uterine cancer	9.22e-06	0.00178	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	8.95e-06	0.00173	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	8.72e-06	0.00169	CbGpPWpGaD
Norgestimate—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	8.48e-06	0.00164	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	8.32e-06	0.00161	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	8.08e-06	0.00156	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—KRAS—uterine cancer	8.04e-06	0.00155	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AKR1B10—uterine cancer	7.93e-06	0.00153	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	7.88e-06	0.00152	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—CDKN2B—uterine cancer	7.62e-06	0.00147	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	7.39e-06	0.00143	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	7.18e-06	0.00139	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AKR1C3—uterine cancer	7.09e-06	0.00137	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—SMAD3—uterine cancer	6.96e-06	0.00135	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—HRAS—uterine cancer	6.83e-06	0.00132	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	6.7e-06	0.0013	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—YWHAE—uterine cancer	6.6e-06	0.00128	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—RNF43—uterine cancer	6.57e-06	0.00127	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FBXW7—uterine cancer	6.32e-06	0.00122	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—PGR—uterine cancer	6.24e-06	0.00121	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	6.15e-06	0.00119	CbGpPWpGaD
Norgestimate—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	6.07e-06	0.00117	CbGpPWpGaD
Norgestimate—ESR1—Signaling by ERBB4—AKT1—uterine cancer	6.03e-06	0.00117	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—INHBA—uterine cancer	6.01e-06	0.00116	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.95e-06	0.00115	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—EZH2—uterine cancer	5.93e-06	0.00115	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—ESR1—uterine cancer	5.68e-06	0.0011	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—STK11—uterine cancer	5.53e-06	0.00107	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—ESR2—uterine cancer	5.49e-06	0.00106	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AKR1C1—uterine cancer	5.41e-06	0.00105	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SOCS3—uterine cancer	5.18e-06	0.001	CbGpPWpGaD
Norgestimate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	5.03e-06	0.000972	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CDKN2B—uterine cancer	4.95e-06	0.000958	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—IGF1R—uterine cancer	4.81e-06	0.000931	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—SMAD3—uterine cancer	4.52e-06	0.000875	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—CDKN2B—uterine cancer	4.47e-06	0.000865	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—FGFR2—uterine cancer	4.31e-06	0.000835	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AKR1C3—uterine cancer	4.16e-06	0.000805	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—SMAD3—uterine cancer	4.08e-06	0.00079	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PGR—uterine cancer	4.06e-06	0.000785	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—YWHAE—uterine cancer	3.87e-06	0.000749	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FBXW7—uterine cancer	3.71e-06	0.000718	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ESR1—uterine cancer	3.69e-06	0.000714	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CCL2—uterine cancer	3.25e-06	0.000629	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—STK11—uterine cancer	3.24e-06	0.000627	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SOCS3—uterine cancer	3.04e-06	0.000587	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CDKN2B—uterine cancer	2.91e-06	0.000562	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—IGF1R—uterine cancer	2.82e-06	0.000546	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—ERBB2—uterine cancer	2.71e-06	0.000524	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—SMAD3—uterine cancer	2.66e-06	0.000514	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CXCL8—uterine cancer	2.57e-06	0.000497	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—FGFR2—uterine cancer	2.53e-06	0.00049	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CDKN1B—uterine cancer	2.51e-06	0.000485	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—CTNNB1—uterine cancer	2.37e-06	0.000459	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PTEN—uterine cancer	2.31e-06	0.000447	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—EP300—uterine cancer	2.2e-06	0.000426	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—VEGFA—uterine cancer	2.09e-06	0.000404	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—NRAS—uterine cancer	2.06e-06	0.000399	CbGpPWpGaD
Norgestimate—PGR—Gene Expression—AKT1—uterine cancer	2.05e-06	0.000396	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CCL2—uterine cancer	1.91e-06	0.000369	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—KRAS—uterine cancer	1.77e-06	0.000343	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—PIK3CA—uterine cancer	1.63e-06	0.000315	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—ERBB2—uterine cancer	1.59e-06	0.000308	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—TP53—uterine cancer	1.58e-06	0.000305	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CXCL8—uterine cancer	1.51e-06	0.000292	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—HRAS—uterine cancer	1.51e-06	0.000292	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CDKN1B—uterine cancer	1.47e-06	0.000285	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—CTNNB1—uterine cancer	1.39e-06	0.000269	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PTEN—uterine cancer	1.36e-06	0.000262	CbGpPWpGaD
Norgestimate—PGR—Signaling Pathways—AKT1—uterine cancer	1.33e-06	0.000258	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—EP300—uterine cancer	1.29e-06	0.00025	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—VEGFA—uterine cancer	1.22e-06	0.000237	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—NRAS—uterine cancer	1.21e-06	0.000234	CbGpPWpGaD
Norgestimate—ESR1—Gene Expression—AKT1—uterine cancer	1.2e-06	0.000232	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—KRAS—uterine cancer	1.04e-06	0.000201	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—PIK3CA—uterine cancer	9.57e-07	0.000185	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—TP53—uterine cancer	9.25e-07	0.000179	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—HRAS—uterine cancer	8.85e-07	0.000171	CbGpPWpGaD
Norgestimate—ESR1—Signaling Pathways—AKT1—uterine cancer	7.82e-07	0.000151	CbGpPWpGaD
